Meet Our People, starring Dr. Craig Cook, CEO of Herantis. With this series, we would like to introduce you to the people behind the scenes at Herantis Pharma Plc. that make it all happen! #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #DrugDevelopment

Welcome Dr. Kira Holmström, Head of Biomarker Research, to the Herantis Pharma Plc. team! With our Meet Our People series, we would like to introduce you to the people behind the scenes at Herantis Pharma Plc. that make it all happen! #HerantisPharma #Biotech #CDNF #xCDNF

Meet Our People, starring Päivi Vuorio, Head of Quality. With this series, we would like to introduce you to the people behind the scenes at Herantis Pharma Plc. that make it all happen! #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #DrugDevelopment

Herantis Pharma Plc. Provides R&D Update and Information About New Biomarker Program: https://t.co/0UKDJ6EB63 #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #healthtech #DrugDevelopment

Herantis Pharma Plc. to Host an R&D Update Webinar on October 26, 2021 at 11:00 EEST / 10:00 CEST. #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #healthtech #DrugDevelopment Register here: https://t.co/MenSWdu30N

Herantis Pharma Plc. Announces Formation of New Scientific Advisory Board with Dr. Anders Gersel Pedersen as Chairman #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #healthtech #DrugDevelopment https://t.co/xlZ7WUXZGa

.@HerantisPharma announces positive results from our Proof of Concept study with them! The nanoforming process has been successfully applied to rhCDNF, a Parkinson’s disease therapy, opening up real possibilities for intranasal administration. Read more: https://t.co/Q9HCkENH9f

Herantis Pharma Announces Successful rhCDNF Results With Nanoform Technology #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #healthtech #DrugDevelopment https://t.co/TZHlIFzVDp

Meet Our People, starring Jani Koskinen, Head of CMC. With this series, we would like to introduce you to the people behind the scenes at Herantis Pharma Plc. that make it all happen! #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #DrugDevelopment

Herantis Pharma to Participate in the Upcoming Virtual Investor Conferences https://t.co/PFjmpH6bdD #pharma #biotech #cdnf #xcdnf #parkinsons #parkinsonsdisease #drugdevelopment #neurodegenerativediseases

Herantis Reports Results for the First Half Year January 1 – June 30, 2021. https://t.co/8wwJ8J7ucj

We are publishing our 1H 2021 Financial Report on 26 August, at 08:00 CEST. A live webinar presentation of the results will be held the same day at 09:30 CEST. https://t.co/tD9AXXSIre

Meet Our People, starring Jutta Poutanen, Head of Quality. With this series, we would like to introduce you to the people behind the scenes at Herantis Pharma Plc. that make it all happen! #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #healthtech

Meet Our People, starring Antti Vuolanto, Chief Operating Officer With this series, we would like to introduce you to the people behind the scenes at Herantis Pharma Plc. that make it all happen. #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying

Herantis Pharma hosted a successful R&D day on June 8th, 2021, powered by Direkt Studios. If you haven’t already seen it, check it out! #HerantisPharma #ParkinsonDisease #Biotech #CDNF #xCDNF #DiseaseModifying #healthtech #DrugDevelopment https://t.co/E80sioBDuK

“We are delighted to host this R&D Day event, and very much look forward to providing an update on the new Herantis as a pure play CNS company”, commented Dr. Craig Cook, CEO of Herantis. #pharma #biotech #cdnf #xcdnf #parkinsons #drugdevelopment https://t.co/TuCQCBR5SO

In case you missed it: CEO, Dr. Craig Cook presented Herantis Pharma at the Redeye Growth Day, June 2, 2021. Follow the link below to view: https://t.co/Uq0rqs5tdv #pharma #biotech #cdnf #xcdnf #parkinsons #parkinsonsdisease #drugdevelopment #neurodegenerativediseases

Herantis Pharma Featured in the June 2021 Nature Journal #pharma #biotech #parkinsonsdisease #parkinson #cdnf #xcdnf #herantis https://t.co/KQQAvXyZeP

Meet Our People, starring Natalia Kulesskaya, Senior Scientist. With this series, we would like to introduce you to the people behind the scenes at Herantis Pharma Plc. that make it all happen. #pharma #biotech #parkinsonsdisease #parkinson #cdnf #xcdnf #herantis

Herantis Pharma Plc. Announces xCDNF Preclinical Candidate Selection #pharma #biotech #ParkinsonsDisease #parkinsons #cdnf #xcdnf #herantis #LeadSelection #drugdevelopment https://t.co/B6MR65jPqi